PRAVACHOL

This brand name is authorized in United States. It is also authorized in Australia, Turkey.

Active ingredients

The drug PRAVACHOL contains one active pharmaceutical ingredient (API):

1	Pravastatin UNII 3M8608UQ61 - PRAVASTATIN SODIUM
	Pravastatin is a competitive inhibitor of 3-hydroxy–3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme catalyzing the early rate limiting step in cholesterol biosynthesis, and produces its lipid lowering effect in two ways.
	Read more about Pravastatin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PRAVACHOL Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AA03	Pravastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2833D, 2834E, 8197K, 8829Q, 9237E, 9238F, 9239G, 9240H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699525016775, 8699525016782, 8699525016799
US	FDA, National Drug Code	0003-5178, 0003-5194